Novocell, Inc.
Novocell, Inc. is a stem cell engineering company creating, delivering and commercializing cell and drug therapies for diabetes and other chronic diseases. The use of human embryonic stem cells provides a scalable source of any differentiated lineage that has potential for cell replacement therapy, as well as tools for drug discovery to create regenerative medicines.
Novocell, Inc., 3550 General Atomics Court, Building 2, Room 503, San Diego, CA 92121, USA. alewis@novocell.com
Alan J
AJ
Lewis
Melissa
M
Carpenter
Allan
A
Robins
Emmanuel
E
Baetge
D000818:Animals; D001709:Biotechnology / Q000379:methods* / Q000458:organization & administration*; D002454:Cell Differentiation / Q000502:physiology; D033041:Embryo Research; D053595:Embryonic Stem Cells / Q000166:cytology*; D004707:Endoderm / Q000378:metabolism; D006801:Humans; D053652:Nuclear Transfer Techniques; D044968:Regenerative Medicine; D023822:Tissue Engineering / Q000379:methods*